Recently recognized ophthalmic complications of systemic treatments

被引：4
作者：
Rousseau, A. [1 ]
Labetoulle, M. [1 ]
机构：
[1] Univ Paris 11, Hop Bicetre, Assistance Publ Hop Paris, Serv ophtalmol,DHU Vis & Handicaps, F-94275 Le Kremlin Bicetre, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2015年 / 38卷 / 09期
关键词：
Ocular adverse effects; Cancer target therapy; Fingolimod; Etanercept; Bisphosphonate; Phosphodiesterase inhibitors; Topiramate; Nicorandil; CENTRAL SEROUS CHORIORETINOPATHY; SILDENAFIL CITRATE; IMATINIB MESYLATE; RETINOPATHY; THERAPY; INHIBITORS; CONJUNCTIVAL; ETANERCEPT; EFFICACY; UVEITIS;
D O I：
10.1016/j.jfo.2015.05.004
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
The ocular side effects of systemic treatments are numerous and sometimes severe. The prescriber and the ophthalmologist should be aware of ocular side effects of systemic treatments in order to inform their patients accordingly, implement appropriate ophthalmological monitoring and/or treatment and if necessary, adapt the therapeutic management. In this review, we describe the recently recognized ophthalmic complications of systemic treatments, except for optic neuropathies. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：876 / 882
页数：7
相关论文
共 52 条
  • [1] Should Central Serous Chorioretinopathy Be Added to the List of Ocular Side Effects of Phosphodiesterase 5 Inhibitors?
    Aliferis, K.
    Petropoulos, I. K.
    Farpour, B.
    Matter, M. A.
    Safran, A. B.
    [J]. OPHTHALMOLOGICA, 2012, 227 (02) : 85 - 89
  • [2] Cotton-Wool Spots and Retinal Hemorrhages
    Andreoli, Michael T.
    Lim, Jennifer I.
    [J]. JAMA OPHTHALMOLOGY, 2014, 132 (04) : 503 - 504
  • [3] Asymptomatic Peripheral Retinal Hemorrhages as a Manifestation of Interferon Beta 1a Retinopathy
    Bakri, Sophie J.
    Swanson, Jerry W.
    [J]. SEMINARS IN OPHTHALMOLOGY, 2015, 30 (01) : 56 - 57
  • [4] Drug-Induced Graves Disease From CTLA-4 Receptor Suppression
    Borodic, Gary
    Hinkle, David M.
    Cia, Yihong
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 27 (04) : E87 - E88
  • [5] Campolmi N, 2013, CUTAN OCUL TOXICOL
  • [6] Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis
    d'Alteroche, L
    Majzoub, S
    Lecuyer, AI
    Delplace, MP
    Bacq, Y
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 56 - 61
  • [7] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    Demetri, GD
    von Mehren, M
    Blanke, CD
    Van den Abbeele, AD
    Eisenberg, B
    Roberts, PJ
    Heinrich, MC
    Tuveson, DA
    Singer, S
    Janicek, M
    Fletcher, JA
    Silverman, SG
    Silberman, SL
    Capdeville, R
    Kiese, B
    Peng, B
    Dimitrijevic, S
    Druker, BJ
    Corless, C
    Fletcher, CDM
    Joensuu, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) : 472 - 480
  • [8] Periorbital Oedema and epiphora as ocular side effects of imatinib Mesylate (Gleevec)
    Esmaeli, B
    Diba, R
    Ahmadi, MA
    Saadati, HG
    Faustina, MM
    Shepler, TR
    Talpaz, M
    Fraunfelder, R
    Rios, MB
    Kantarjian, H
    [J]. EYE, 2004, 18 (07) : 760 - 762
  • [9] Interferon β-associated retinopathy in patients treated for multiple sclerosis
    Folden, David V.
    Lee, Michael S.
    Ryan, Edwin H., Jr.
    [J]. NEUROLOGY, 2008, 70 (13) : 1153 - 1155
  • [10] Interferon Alfa-associated Anterior Ischemic Optic Neuropathy
    Fraunfelder, F. W.
    Fraunfelder, F. T.
    [J]. OPHTHALMOLOGY, 2011, 118 (02) : 408 - U203
123456